[HTML][HTML] A systematic review informing the management of symptomatic brain radiation necrosis after stereotactic radiosurgery and international stereotactic …
B Vellayappan, MJ Lim-Fat, R Kotecha… - International Journal of …, 2024 - Elsevier
Background Radiation necrosis (RN) secondary to stereotactic radiosurgery is a significant
cause of morbidity. The optimal management of corticosteroid-refractory brain RN remains …
cause of morbidity. The optimal management of corticosteroid-refractory brain RN remains …
Treatment of central nervous system tumors on combination MR-linear accelerators: review of current practice and future directions
JM Bryant, A Doniparthi, J Weygand, R Cruz-Chamorro… - Cancers, 2023 - mdpi.com
Simple Summary Magnetic resonance imaging (MRI) has several advantages over
computerized tomography (CT) in the treatment planning of central nervous system (CNS) …
computerized tomography (CT) in the treatment planning of central nervous system (CNS) …
[HTML][HTML] Central nervous system metastases in advanced non-small cell lung cancer: A review of the therapeutic landscape central nervous system metastases in …
Up to 40% of patients with non-small cell lung cancer (NSCLC) develop central nervous
system (CNS) metastases. Current treatments for this subgroup of patients with advanced …
system (CNS) metastases. Current treatments for this subgroup of patients with advanced …
Modern stereotactic radiotherapy for brain metastases from lung cancer: current trends and future perspectives based on integrated translational approaches
M Levis, A Gastino, G De Giorgi, C Mantovani… - Cancers, 2023 - mdpi.com
Simple Summary In the current era of precision medicine, the management of patients with
brain metastases (BMs) is rapidly evolving. The technical evolution of radiotherapy, now …
brain metastases (BMs) is rapidly evolving. The technical evolution of radiotherapy, now …
Novel mechanisms and future opportunities for the management of radiation necrosis in patients treated for brain metastases in the era of immunotherapy
Simple Summary As the incidence and survival of patients with brain metastases improve,
the burden of treatment-related neurotoxicities will increase for patients and healthcare …
the burden of treatment-related neurotoxicities will increase for patients and healthcare …
Stereotactic radiosurgery and stereotactic fractionated radiotherapy in the management of brain metastases
S Benkhaled, L Schiappacasse, A Awde, R Kinj - Cancers, 2024 - mdpi.com
Simple Summary The management of brain metastases (BM) is a major issue in cancer
treatment, and one of the main goals of BM treatment is to achieve effective disease control …
treatment, and one of the main goals of BM treatment is to achieve effective disease control …
[PDF][PDF] Phase II multicenter trial combining nivolumab and radiosurgery for NSCLC and RCC brain metastases
P Wong, L Masucci, M Florescu… - Neuro-Oncology …, 2023 - academic.oup.com
Background Anti-PD-1 has activity in brain metastases (BM). This phase II open labeled non-
randomized single arm trial examined the safety and efficacy of combining nivolumab with …
randomized single arm trial examined the safety and efficacy of combining nivolumab with …
Stereotactic radiosurgery for brain metastases from human epidermal receptor 2 positive breast Cancer: an international, multi-center study
Purpose To report patient outcomes and local tumor control rates in a cohort of patients with
biopsy-proven HER-2 positive breast cancer treated with stereotactic radiosurgery (SRS) for …
biopsy-proven HER-2 positive breast cancer treated with stereotactic radiosurgery (SRS) for …
Immune checkpoint inhibition and single fraction stereotactic radiosurgery in brain metastases from non-small cell lung cancer: an international multicenter study of …
Purpose Approximately 80% of brain metastases originate from non-small cell lung cancer
(NSCLC). Immune checkpoint inhibitors (ICI) and stereotactic radiosurgery (SRS) are …
(NSCLC). Immune checkpoint inhibitors (ICI) and stereotactic radiosurgery (SRS) are …
Combination of radiosurgery and immunotherapy in brain metastases: balance between efficacy and toxicities
A Botticella, F Dhermain - Current Opinion in Neurology, 2023 - journals.lww.com
The efficacy/toxicity balance of SRS-ICI combination should be regularly re-evaluated,
anticipating continued progress in ICI and SRS delivery, with more long-survivors potentially …
anticipating continued progress in ICI and SRS delivery, with more long-survivors potentially …